跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,430 条关于
“Dimerix Limited”
全部
11,430
临床试验
1,191
药物
62
机构
1,332
资讯
8,845
去年
PARASOL Workshop Suggests Broader Proteinuria Endpoints for FSGS Drug Approval
11个月前
Dimerix's DMX-200 Receives Orphan Drug Designation in Japan for Rare Kidney Disease Treatment
去年
Dimerix Advances Kidney Disease Trial with Key Endpoint Validation
去年
Dimerix Partners with NEPTUNE to Accelerate FSGS Trial Recruitment
去年
Dimerix Licenses Phase 3 FSGS Drug DMX-200 to FUSO Pharma for ¥10.5 Billion
去年
FDA Confirms Proteinuria as Primary Endpoint for Dimerix's DMX-200 Phase 3 FSGS Trial
去年
Dimerix's ACTION3 Phase 3 Trial for FSGS Receives Positive IDMC Review
2年前
Dimerix's DMX-200 Shows Promise in Phase 3 Trial for Rare Kidney Disease FSGS
去年
Dimerix's Phase 3 Trial of DMX-200 for FSGS Completes Part 2 Recruitment, Interim Analysis Expected in August 2025
9个月前
Dimerix Completes Recruitment for Phase 3 Trial of DMX-200 in Rare Kidney Disease FSGS
第 1 页,共 885 页
上一页
下一页